
Filters: Author is Kung [Clear All Filters]
Search Results
- Showing 1-7 of 7 Results
Proteomic and genetic approaches identify Syk as an AML target. Cancer cell, 2009/10/06, Volume 16, Issue 4, p.281-94, (2009)
Read More / View Supplemental Materials
Abstract
Identification of AML1-ETO modulators by chemical genomics. Blood, 2009/06/11, Volume 113, Issue 24, p.6193-205, (2009)
Read More / View Supplemental Materials
Abstract
Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy. Nature biotechnology, 2009/01/01, Volume 27, Issue 1, p.77-83, (2009)
Read More / View Supplemental Materials
Abstract
Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation Proceedings of the National Academy of Sciences of the United States of America, 2008/07/15/, Volume 105, Issue 28, p.9751 - 6, (2008)
Read More / View Supplemental Materials
Abstract
Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation. Proceedings of the National Academy of Sciences of the United States of America, 2008/07/15, Volume 105, Issue 28, p.9751-6, (2008)
Read More / View Supplemental Materials
Abstract
Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma. PLoS medicine, 2007/04/01, Volume 4, Issue 4, p.e122, (2007)
Read More / View Supplemental Materials
Abstract
Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma PLoS Medicine, 2007/04//, Volume 4, Issue 4, p.e122 - e122, (2007)
Read More / View Supplemental Materials
Abstract
- Showing 1-7 of 7 Results
